In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Point-of-care Infectious Disease Diagnostics market for 2018-2023.
Point of care diagnosis allows for early detection of diseases and can greatly impact the medical outcome of the disease treatment.
The point-of-care infectious disease diagnostics market is expected to register a fast growth over the forecast period owing to the emerging trend of patient-centric services and escalating incidence rates of complicated infectious disorders.
Over the next five years, LPI(LP Information) projects that Point-of-care Infectious Disease Diagnostics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares and growth opportunities of Point-of-care Infectious Disease Diagnostics market by product type, application, key companies and key regions.
To calculate the market size, LP Information considers value generated from the sales of the following segments:
Segmentation by product type:
Clostridium Difficile POC
Respiratory Syncytial Virus POC
TB and Drug-Resistant TB POC
Segmentation by application:
Assisted Living Healthcare Facilities
We can also provide the customized separate regional or country-level reports, for the following regions:
Middle East & Africa
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Thermo Fisher Scientific
Chembio Diagnostic Systems
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
To study and analyze the global Point-of-care Infectious Disease Diagnostics market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Point-of-care Infectious Disease Diagnostics market by identifying its various subsegments.
Focuses on the key global Point-of-care Infectious Disease Diagnostics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Point-of-care Infectious Disease Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Point-of-care Infectious Disease Diagnostics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.